PMC:7156805 / 242-402 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"8","span":{"begin":20,"end":29},"obj":"Disease"},{"id":"9","span":{"begin":84,"end":93},"obj":"Disease"},{"id":"10","span":{"begin":118,"end":142},"obj":"Disease"},{"id":"11","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"tao:has_database_id","subj":"8","obj":"MESH:D007239"},{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"MESH:D011565"},{"id":"A10","pred":"tao:has_database_id","subj":"10","obj":"MESH:C000657245"},{"id":"A11","pred":"tao:has_database_id","subj":"11","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rtinent overview of infection risk associated with commonly used biologics to treat psoriasis in light of the current coronavirus disease 2019 (COVID-19) outbre"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":20,"end":29},"obj":"Disease"},{"id":"T3","span":{"begin":84,"end":93},"obj":"Disease"},{"id":"T4","span":{"begin":118,"end":142},"obj":"Disease"},{"id":"T5","span":{"begin":144,"end":152},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005083"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"rtinent overview of infection risk associated with commonly used biologics to treat psoriasis in light of the current coronavirus disease 2019 (COVID-19) outbre"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":84,"end":93},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0003765"}],"text":"rtinent overview of infection risk associated with commonly used biologics to treat psoriasis in light of the current coronavirus disease 2019 (COVID-19) outbre"}